Literature DB >> 26376348

Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity.

Elisa Fabbrini1, Courtney Tiemann Luecking1, Latisha Love-Gregory1, Adewole L Okunade1, Mihoko Yoshino1, Gemma Fraterrigo1, Bruce W Patterson1, Samuel Klein2.   

Abstract

Weight gain is associated with an increase in intrahepatic triglycerides (IHTGs), and is the primary cause of nonalcoholic fatty liver disease in obese individuals. We combined imaging and stable isotope tracer techniques to evaluate the physiologic mechanisms of weight gain-induced steatosis in 27 obese people. Weight gain appeared to increase IHTG content by generating an imbalance between hepatic fatty acid availability and disposal, and resulted in increased hepatic de novo lipogenesis, decreased intrahepatic fatty acid oxidation, and inadequate increases in IHTG export via very low-density lipoprotein secretion. ClinicalTrials.gov ID NCT01184170.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fatty Acid Oxidation; Overweight; VLDL; apoB100

Mesh:

Substances:

Year:  2015        PMID: 26376348      PMCID: PMC4691551          DOI: 10.1053/j.gastro.2015.09.003

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

Authors:  Elisa Fabbrini; B Selma Mohammed; Faidon Magkos; Kevin M Korenblat; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

Review 2.  Regulation of in vivo ketogenesis: role of free fatty acids and control by epinephrine, thyroid hormones, insulin and glucagon.

Authors:  M Beylot
Journal:  Diabetes Metab       Date:  1996-10       Impact factor: 6.041

3.  Metabolically normal obese people are protected from adverse effects following weight gain.

Authors:  Elisa Fabbrini; Jun Yoshino; Mihoko Yoshino; Faidon Magkos; Courtney Tiemann Luecking; Dmitri Samovski; Gemma Fraterrigo; Adewole L Okunade; Bruce W Patterson; Samuel Klein
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

4.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

5.  Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.

Authors:  Takeshi Kimura; Gautam A Deshpande; Kevin Y Urayama; Katsunori Masuda; Tsuguya Fukui; Yutaka Matsuyama
Journal:  J Gastroenterol Hepatol       Date:  2015-05       Impact factor: 4.029

6.  Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans.

Authors:  R J Havel; J P Kane; E O Balasse; N Segel; L V Basso
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

Review 7.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

8.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330

  8 in total
  14 in total

1.  Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes.

Authors:  Yan Liu; Haiyan Lin; Lin Jiang; Qingsen Shang; Lei Yin; Jiandie D Lin; Wen-Shu Wu; Liangyou Rui
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

2.  VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women.

Authors:  Bettina Mittendorfer; Mihoko Yoshino; Bruce W Patterson; Samuel Klein
Journal:  J Clin Endocrinol Metab       Date:  2016-09-02       Impact factor: 5.958

3.  Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.

Authors:  David E Stec; Darren M Gordon; Jennifer A Hipp; Stephen Hong; Zachary L Mitchell; Natalia R Franco; J Walker Robison; Christopher D Anderson; Donald F Stec; Terry D Hinds
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-04       Impact factor: 3.619

4.  Sugar, Sugar . . . Not So Sweet for the Liver.

Authors:  Miriam B Vos; Michael I Goran
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 33.883

5.  Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects.

Authors:  Yoshihiro Kamada; Ryota Hashimoto; Hidenaga Yamamori; Yuka Yasuda; Tetsuo Takehara; Yuko Fujita; Kenji Hashimoto; Eiji Miyoshi
Journal:  BBA Clin       Date:  2016-02-23

6.  Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain.

Authors:  Thomas Scherer; Claudia Lindtner; James O'Hare; Martina Hackl; Elizabeth Zielinski; Angelika Freudenthaler; Sabina Baumgartner-Parzer; Klaus Tödter; Joerg Heeren; Martin Krššák; Ludger Scheja; Clemens Fürnsinn; Christoph Buettner
Journal:  Diabetes       Date:  2016-02-09       Impact factor: 9.461

7.  Comparative Study on the Cellular and Systemic Nutrient Sensing and Intermediary Metabolism after Partial Replacement of Fishmeal by Meat and Bone Meal in the Diet of Turbot (Scophthalmus maximus L.).

Authors:  Fei Song; Dandan Xu; Kangsen Mai; Huihui Zhou; Wei Xu; Gen He
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

8.  Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver.

Authors:  Tomas Jelenik; Kirti Kaul; Gilles Séquaris; Ulrich Flögel; Esther Phielix; Jörg Kotzka; Birgit Knebel; Pia Fahlbusch; Tina Hörbelt; Stefan Lehr; Anna Lena Reinbeck; Dirk Müller-Wieland; Irene Esposito; Gerald I Shulman; Julia Szendroedi; Michael Roden
Journal:  Diabetes       Date:  2017-05-10       Impact factor: 9.461

Review 9.  The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.

Authors:  Francesco Massimo Perla; Maurizia Prelati; Michela Lavorato; Daniele Visicchio; Caterina Anania
Journal:  Children (Basel)       Date:  2017-06-06

10.  Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.

Authors:  Lídia Cedó; David Santos; Núria Roglans; Josep Julve; Victor Pallarès; Andrea Rivas-Urbina; Vicenta Llorente-Cortes; Joan Carles Laguna; Francisco Blanco-Vaca; Joan Carles Escolà-Gil
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.